If you used chemical hair relaxer products regularly and were later diagnosed with uterine or ovarian cancer, you may qualify for compensation.
Lawsuits allege that chemical hair relaxer and straightening products are linked to an increased risk of uterine, ovarian, and other cancers, and that manufacturers failed to warn users of the risk. The litigation has particularly focused on the impact on Black women, who have historically been the primary users of these products.
This is now one of the largest active mass-tort dockets in the country by number of plaintiffs.
Here's what happens after you reach out:
A short set of free eligibility questions about your situation — takes about two minutes.
Our network reviews your answers against current qualifying criteria and reaches out if you may qualify.
You decide whether to move forward. There's never a cost to check your eligibility.
As of July 2026, nearly 11,900 plaintiffs are part of the federal hair relaxer MDL before Judge Mary Rowland in the Northern District of Illinois. The litigation is currently in bellwether discovery and Daubert (expert-evidence) briefing — a phase that will help define eventual settlement values. Bellwether trials aren't expected before 2027, meaning any settlements are unlikely before 2027 or 2028.
Get updates on hair relaxer, plus other case types we cover.
We'll keep you updated on hair relaxer and other case types.